EVALUATION OF RISK OF MALIGNANCY INDICES 1, 2, AND 3 IN PRE-OPERATIVE ASSESSMENT OF THE OVARIAN MASSES. Journal of Pharmaceutical Negative Results 2022, 3275-3282.